Feasibility of sequential treatment with CD19-targeted agents in patients with LBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:26 1 year ago 116 Далее Скачать
The sequencing of CD19-targeting CAR-Ts and CD20-targeting bispecifics in DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 6:38 6 months ago 251 Далее Скачать
Determining which CD19-directed CAR-T product is best for each patient with LBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:01 1 year ago 97 Далее Скачать
CD19-Targeting in Relapsed/Refractory DLBCL: Optimizing the Use of Noncellular Therapies Medscape 27:20 3 months ago 12 Далее Скачать
Risk factors to predict post-CD19 CAR-T cell therapy outcomes in patients with LBCL VJHemOnc – Video Journal of Hematology & HemOnc 4:05 1 year ago 173 Далее Скачать
Feasibility of second CART19 administration with rituximab-based lymphodepletion in R/R B-ALL VJHemOnc – Video Journal of Hematology & HemOnc 2:26 1 year ago 51 Далее Скачать
Advances in CD22/CD19 CAR-T sequential therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:01 2 years ago 61 Далее Скачать
Treatment of R/R DLBCL: CD19-Targeted Monoclonal Antibodies Targeted Oncology 4:46 4 years ago 50 Далее Скачать
CD19-Targeted CAR T-Cell Therapy in Managing DLBCL Targeted Oncology 8:33 4 years ago 94 Далее Скачать
The role of alloSCT for R/R LBCL in the era of CAR-T therapy VJHemOnc – Video Journal of Hematology & HemOnc 0:44 1 year ago 114 Далее Скачать
Outcomes of delaying CAR-T infusion after lymphodepleting chemotherapy in patients with LBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:50 1 year ago 161 Далее Скачать
The Next Phase of Targeted Therapy in MCL and DLBCL PeerView Oncology 1:19:12 1 year ago 192 Далее Скачать
Approaching the treatment of patients with LBCL who relapse after bispecific antibodies VJHemOnc – Video Journal of Hematology & HemOnc 2:38 1 month ago 114 Далее Скачать
Glofitamab as a SOC in third-line DLBCL and its potential in earlier lines of therapy VJHemOnc – Video Journal of Hematology & HemOnc 1:22 1 year ago 265 Далее Скачать
Efficacy of bispecific CD19/CD22 CAR T-cells in B-cell malignancies VJHemOnc – Video Journal of Hematology & HemOnc 2:37 2 years ago 1 016 Далее Скачать
CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell ALL ASCOcancer 2:36 1 year ago 4 932 Далее Скачать
Siltuximab for first-line treatment of CRS in patients receiving CAR-T therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:42 1 year ago 135 Далее Скачать
CD19 and CD20 CAR T-cell therapy for non-Hodgkin lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 2:22 5 years ago 5 830 Далее Скачать
Correlation between ctDNA levels and outcomes in patients with NHL treated with CAR-T therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:48 1 year ago 74 Далее Скачать
